853
Views
285
CrossRef citations to date
0
Altmetric
Invited Editorial

KEEPS: The Kronos Early Estrogen Prevention Study

, , , , , , , & show all
Pages 3-12 | Received 19 Oct 2004, Accepted 03 Dec 2004, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (43)

V. M. Miller, H. S. Taylor, F. Naftolin, J. E. Manson, C. E. Gleason, E. A. Brinton, J. M. Kling, M. I. Cedars, N. M. Dowling, K. Kantarci & S. M. Harman. (2021) Lessons from KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 24:2, pages 139-145.
Read now
L. Raz, L. V. Hunter, N. M. Dowling, W. Wharton, C. E. Gleason, M. Jayachandran, L. Anderson, S. Asthana & V. M. Miller. (2016) Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS. Climacteric 19:1, pages 49-59.
Read now
Virginia M. Miller, Brian D. Lahr, Kent R. Bailey, John A. Heit, S. Mitchell Harman & Muthuvel Jayachandran. (2016) Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles. Platelets 27:1, pages 32-42.
Read now
Anna Fenton & Nick Panay. (2015) Hormone therapy and cardiovascular disease – are we back to the beginning?. Climacteric 18:4, pages 437-438.
Read now
Anna Fenton & Nick Panay. (2015) KEEPS, GSM and much more. Climacteric 18:2, pages 107-107.
Read now
J. M. Kling, B. A. Lahr, K. R. Bailey, S. M. Harman, V. M. Miller & S. L. Mulvagh. (2015) Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric 18:2, pages 187-197.
Read now
Pauliina Tuomikoski & Tomi S. Mikkola. (2014) Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women. Annals of Medicine 46:1, pages 1-7.
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Nick Panay & Anna Fenton. (2012) Good news for HRT – what next?. Climacteric 15:6, pages 511-512.
Read now
Y. Miyabara, D. Holmes$suffix/text()$suffix/text(), J. Camp, V. M. Miller & A. E. Kearns. (2012) Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women. Climacteric 15:4, pages 374-381.
Read now
Nicole Weinberg, Amelia Young, Carol J. Hunter, Nisha Agrawal, Songshou Mao & Matthew J. Budoff. (2012) Physical Activity, Hormone Replacement Therapy, and the Presence of Coronary Calcium in Midlife Women. Women & Health 52:5, pages 423-436.
Read now
R. D. Langer, J. E. Manson & M. A. Allison. (2012) Have we come full circle – or moved forward? The Women's Health Initiative 10 years on. Climacteric 15:3, pages 206-212.
Read now
D. F. Archer & E. Oger. (2012) Estrogen and progestogen effect on venous thromboembolism in menopausal women. Climacteric 15:3, pages 235-240.
Read now
H. G. Burger, A. H. MacLennan, K-E. Huang & C. Castelo-Branco. (2012) Evidence-based assessment of the impact of the WHI on women's health. Climacteric 15:3, pages 281-287.
Read now
Nick Panay. (2012) Body-identical hormone replacement. Climacteric 15:sup1, pages 1-2.
Read now
Nick Panay & Anna Fenton. (2012) Does HRT increase the risk of breast cancer? Don't forget the menopausal woman!. Climacteric 15:2, pages 103-104.
Read now
S. M. O'Neill, J. Liu, M. F. O'Rourke & S. K. Khoo. (2012) The menopausal transition does not appear to accelerate age-related increases in arterial stiffness. Climacteric 16:1, pages 62-69.
Read now
I. J. Kerber & R. J. Turner. (2011) When will the WHI investigators acknowledge what they are saying?. Climacteric 14:5, pages 597-597.
Read now
Y. Miyabara, J. Camp, D. Holmes$suffix/text()$suffix/text(), B. Lahr, K. Bailey, V. M. Miller & A. E. Kearns. (2011) Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric 14:4, pages 438-444.
Read now
Anna Fenton & Nick Panay. (2011) Seismic shifts. Climacteric 14:3, pages 301-301.
Read now
MR Davey. (2010) The role of hormone therapy in the treatment of osteoporosis. Journal of Endocrinology, Metabolism and Diabetes of South Africa 15:1, pages 49-51.
Read now
Nick Panay & Anna Fenton. (2010) Bioidentical hormones: what is all the hype about?. Climacteric 13:1, pages 1-3.
Read now
S. L. Mulvagh, T. Behrenbeck, B. A. Lahr, K. R. Bailey, T. G. Zais, P. A. Araoz & V. M. Miller. (2010) Endothelial function and cardiovascular risk stratification in menopausal women. Climacteric 13:1, pages 45-54.
Read now
Joshua Thomas & Anji T Yetman. (2009) Management of cardiovascular disease in Turner syndrome. Expert Review of Cardiovascular Therapy 7:12, pages 1631-1641.
Read now
Vera Bittner. (2009) Postmenopausal hormone therapy and the risk of cardiovascular disease. Expert Opinion on Pharmacotherapy 10:13, pages 2041-2053.
Read now
N. Panay. (2009) Estrogen dose: the cardiovascular impact. Climacteric 12:sup1, pages 91-95.
Read now
M. Jayachandran, R. D. Litwiller, W. G. Owen & V. M. Miller. (2009) Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 12:2, pages 177-184.
Read now
Nathan W Kopper, Jennifer Gudeman & Daniel J Thompson. (2008) Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies. Drug Design, Development and Therapy 2, pages 193-202.
Read now
Richard E Hedrick. (2008) Low-dose estradiol gel 0.1% for the treatment of vasomotor symptoms associated with menopause. Expert Review of Obstetrics & Gynecology 3:2, pages 155-162.
Read now
Nick Panay & Anna Fenton. (2008) HRT: does the dose matter?. Climacteric 11:3, pages 177-178.
Read now
M. H. Birkhäuser, M. H. Birkhäuser, N. Panay, D. F. Archer, D. Barlow, H. Burger, M. Gambacciani, S. Goldstein, J. A. Pinkerton & D. W. Sturdee. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 11:2, pages 108-123.
Read now
Vera V Koledova & Raouf A Khalil. (2007) Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert Review of Cardiovascular Therapy 5:4, pages 777-789.
Read now
M Davey. (2007) Reducing the risk of cardiovascular disease in older women. South African Family Practice 49:5, pages 32-35.
Read now
Thomas Dayspring & Gregory Pokrywka. (2007) Pharmacotherapeutic Decisions In Menopausal Women With Cardiovascular Risk. Future Lipidology 2:2, pages 197-210.
Read now
Amos Pines, David W. Sturdee, Alastair H. MacLennan, Hermann P. G. Schneider, Henry Burger & Anna Fenton. (2007) The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 10:4, pages 267-269.
Read now
C. F. Holinka, M. A. Karsdal & C. Christiansen. (2007) Bone, cartilage and hormone therapy: established concepts and future scenarios. Climacteric 10:4, pages 270-272.
Read now
Alastair H. MacLennan & David W. Sturdee$suffix/text()$suffix/text(). (2007) Long-term trials of HRT for cardioprotection – is this as good as it gets?. Climacteric 10:1, pages 1-4.
Read now
Danielle Vitiello, Frederick Naftolin & Hugh S. Taylor. (2007) Menopause: Developing a rational treatment plan. Gynecological Endocrinology 23:12, pages 682-691.
Read now

Articles from other publishers (242)

Kejal Kantarci, Nirubol Tosakulwong, Timothy G. Lesnick, Firat Kara, June Kendall-Thomas, Ekta Kapoor, Julie A. Fields, Taryn T. James, Rogerio A. Lobo, JoAnn E. Manson, Lubna Pal, Dustin B. Hammers, Michael Malek-Ahmadi, Marcelle I. Cedars, Frederick N. Naftolin, Nanette Santoro, Virginia M. Miller, Sherman M. Harman, N. Maritza DowlingCarey E. Gleason. (2023) Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause.
Crossref
Mariam SaadedineStephanie S. FaubionJuliana M. Kling & Ekta Kapoor. (2023) Cognitive Health Update in Midlife Women. Journal of Women's Health.
Crossref
Grace Zhang, Perry Devo, Valerie B. O'Leary & Saak V. Ovsepian. (2023) Ageing perspective on cognitive outcomes from ancillary reproductive hormone adjustments. Heliyon 9:8, pages e19050.
Crossref
J Piťha, I Vaněčková & J Zicha. (2023) Hypertension after the Menopause: What Can We Learn from Experimental Studies?. Physiological Research, pages S91-S112.
Crossref
Guilherme Renke, Elaine Kemen, Priscila Scalabrin, Cleibe Braz, Thomaz Baesso & Marcela Batista Pereira. (2023) Cardio-Metabolic Health and HRT in Menopause: Novel Insights in Mitochondrial Biogenesis and RAAS. Current Cardiology Reviews 19:4.
Crossref
Bernd Kleine-Gunk. (2023) Hormonersatztherapie bei Frauen über 65 Jahren. gynäkologie + geburtshilfe 28:1, pages 38-39.
Crossref
Juliana M. Kling, N. Maritza Dowling, Heather Bimonte-Nelson, Carey E. Gleason, Kejal Kantarci, Cynthia M. Stonnington, S. Mitch Harman, Frederick Naftolin, Lubna Pal, Marcelle Cedars, JoAnn E. Manson, Taryn T. James, Eliot A. Brinton & Virginia M. Miller. (2023) Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy. Maturitas 167, pages 113-122.
Crossref
Lavanya Cherukuri, April Kinninger, Divya Birudaraju, Eranthi Jayawardena, Venkat Sanjay Manubolu, Eliot A. Brinton, Dennis Black, Virginia Miller, Ann E. Kearns, JoAnn E. Manson, Matthew J. Budoff & Sion K. Roy. (2022) Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?. Clinical Imaging 90, pages 26-31.
Crossref
Kathy Pan, Sayeh Lavasani, Aaron K. Aragaki & Rowan T. Chlebowski. (2022) Estrogen therapy and breast cancer in randomized clinical trials: a narrative review. Menopause 29:9, pages 1086-1092.
Crossref
Bharti Manwani, Carson Finger & Lynda Lisabeth. (2022) Strategies for Maintaining Brain Health: The Role of Stroke Risk Factors Unique to Elderly Women. Stroke 53:8, pages 2662-2672.
Crossref
Lubna Pal, Kelly Morgan, Nanette F. Santoro, JoAnn E. Manson, Hugh S. Taylor, Virginia M. Miller, Eliot A. Brinton, Rogerio Lobo, Genevieve Neal-Perry, Marcelle I. Cedars, S. Mitchell Harman, Taryn T. James & Carey E. Gleason. (2022) Cardiometabolic measures and cognition in early menopause - Analysis of baseline data from a randomized controlled trial. Maturitas 162, pages 58-65.
Crossref
Megan Herson & Jayashri Kulkarni. (2022) Hormonal Agents for the Treatment of Depression Associated with the Menopause. Drugs & Aging 39:8, pages 607-618.
Crossref
Mario Gaudino, Antonino Di Franco, Davide Cao, Gennaro Giustino, C. Noel Bairey Merz, Stephen E. Fremes, Ajay J. Kirtane, Vijay Kunadian, Jennifer S. Lawton, Ruth Marie Masterson Creber, Sigrid Sandner, Birgit Vogel, Brittany A. Zwischenberger, George D. Dangas & Roxana Mehran. (2022) Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease. Journal of the American College of Cardiology 79:14, pages 1407-1425.
Crossref
Meijun PanXinyao PanJing ZhouJing WangQing QiLing Wang. (2022) Update on hormone therapy for the management of postmenopausal women. BioScience Trends 16:1, pages 46-57.
Crossref
Sindhu Prabakaran, Sophie Vitter & Gina Lundberg. (2022) Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy. Endocrine Practice 28:2, pages 199-203.
Crossref
Jennifer E. Taylor, Mariam S. Baig, Tarek Helmy & Felice L. Gersh. (2020) Controversies Regarding Postmenopausal Hormone Replacement Therapy for Primary Cardiovascular Disease Prevention in Women. Cardiology in Review 29:6, pages 296-304.
Crossref
Michelle M. Mielke & Virginia M. Miller. (2021) Improving clinical outcomes through attention to sex and hormones in research. Nature Reviews Endocrinology 17:10, pages 625-635.
Crossref
Donald J. AbrahamCarlo I. Rosales, Lauren M. Gutgesell, Kiira M. Ratia & Gregory R.J. Thatcher. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 74 .
Muthuvel Jayachandran, Virginia M. Miller, Brian D. Lahr, Kent R. Bailey, Val J. Lowe, Julie A. Fields, Michelle M. Mielke & Kejal Kantarci. (2021) Peripheral Markers of Neurovascular Unit Integrity and Amyloid-β in the Brains of Menopausal Women. Journal of Alzheimer's Disease 80:1, pages 397-405.
Crossref
Burcu Zeydan, Val J. Lowe, Nirubol Tosakulwong, Timothy G. Lesnick, Matthew L. Senjem, Clifford R. Jack, Julie A. Fields, Taryn T. James, Carey E. Gleason, N. Maritza Dowling, Virginia M. Miller & Kejal Kantarci. (2021) Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study. NeuroReport Publish Ahead of Print.
Crossref
Sindhu Prabakaran, Arielle Schwartz & Gina Lundberg. (2021) Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use. Therapeutic Advances in Endocrinology and Metabolism 12, pages 204201882110139.
Crossref
Saioa Torrealday & Lubna Pal. (2021) Primary ovarian insufficiency – Why, nearing 2021, are we still debating “to treat or not?”. Maturitas 143, pages 231-233.
Crossref
Ijeoma C. Eleazu, Maeve Jones-O’Connor & Michael C. Honigberg. (2020) The Impact of Premature Menopause on Future Risk of Cardiovascular Disease. Current Treatment Options in Cardiovascular Medicine 22:12.
Crossref
Laura Faubion, Thomas A. White, Brett J. Peterson, Jennifer R. Geske, Nathan K. LeBrasseur, Marissa J. Schafer, Michelle M. Mielke & Virginia M. Miller. (2020) Effect of menopausal hormone therapy on proteins associated with senescence and inflammation. Physiological Reports 8:16.
Crossref
Juliana M. Kling, Virginia M. Miller, Nirubol Tosakulwong, Timothy Lesnick & Kejal Kantarci. (2020) Associations of pituitary-ovarian hormones and white matter hyperintensities in recently menopausal women using hormone therapy. Menopause 27:8, pages 872-878.
Crossref
Tatiana V. Kirichenko, Veronika A. Myasoedova, Alessio L. Ravani, Igor A. Sobenin, Varvara A. Orekhova, Elena B. Romanenko, Paolo Poggio, Wei-Kai Wu & Alexander N. Orekhov. (2020) Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study. Biology 9:3, pages 48.
Crossref
Katrine Yare & Michael Woodward. (2020) Hormone Therapy and Effects on Sporadic Alzheimer’s Disease in Postmenopausal Women: Importance of Nomenclature. Journal of Alzheimer's Disease 73:1, pages 23-37.
Crossref
Virginia M. Miller, Muthuvel Jayachandran, Jill N. Barnes, Michelle M. Mielke, Kejal Kantarci & Walter A. Rocca. (2019) Risk factors of neurovascular ageing in women. Journal of Neuroendocrinology 32:1.
Crossref
Amanda Rosenthal, Ted Jacoby, Rachel Israilevich & Ronald Moy. (2019) The role of bioidentical hormone replacement therapy in anti‐aging medicine: a review of the literature. International Journal of Dermatology 59:1, pages 23-29.
Crossref
Samar R. El Khoudary, Vidya Venugopal, JoAnn E. Manson, Maria M. Brooks, Nanette Santoro, Dennis M. Black, Mitchell Harman, Frederick Naftolin, Howard N. Hodis, Eliot A. Brinton, Virginia M. Miller, Hugh S. Taylor & Matthew J. Budoff. (2020) Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial. Menopause 27:3, pages 255-262.
Crossref
Muthuvel Jayachandran, Brian D. Lahr, Kent R. Bailey, Virginia M. Miller & Kejal Kantarci. (2020) Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study. Menopause 27:3, pages 305-310.
Crossref
Juliana M. Kling, N. Maritza DowlingHeather A. Bimonte-Nelson, Carey E. Gleason, Kejal Kantarci, JoAnn E. Manson, Hugh S. Taylor, Eliot A. Brinton, Rogerio A. Lobo, Marcelle I. Cedars, Lubna Pal, Genevieve Neal-Perry, Frederick Naftolin, S. Mitchell Harman & Virginia M. Miller. (2019) Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 317:6, pages R912-R920.
Crossref
Theresa Elder, Alankrita Raghavan, Arvin Smith, Christina Huang Wright, James Wright, Christopher Burant, Martha Sajatovic & Alan Hoffer. (2019) Outcomes After Intracranial Hemorrhage in Patients with Left Ventricular Assist Devices: A Systematic Review of Literature. World Neurosurgery 132, pages 265-272.
Crossref
C. Mounier-Vehier, T. Angoulvant, J.M. Boivin & G. Plu-Bureau. (2019) HTA et traitement hormonal de la menopause. La Presse Médicale 48:11, pages 1295-1300.
Crossref
Virginia M. Miller, Fredrick Naftolin, Sanjay Asthana, Dennis M. Black, Eliot A. Brinton, Matthew J. Budoff, Marcelle I. Cedars, N. Maritza Dowling, Carey E. Gleason, Howard N. Hodis, Muthuvel Jayachandran, Kejal Kantarci, Rogerio A. Lobo, JoAnn E. Manson, Lubna Pal, Nanette F. Santoro, Hugh S. Taylor & S. Mitchell Harman. (2019) The Kronos Early Estrogen Prevention Study (KEEPS). Menopause 26:9, pages 1071-1084.
Crossref
Samar R. El Khoudary, Qian Zhao, Vidya Venugopal, JoAnn E. Manson, Maria M. Brooks, Nanette Santoro, Dennis M. Black, S. Mitchell Harman, Marcelle I. Cedars, Paul N. Hopkins, Ann E. Kearns, Virginia M. Miller, Hugh S. Taylor & Matthew J. Budoff. (2019) Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial. Journal of the American Heart Association 8:15.
Crossref
Yasina B. Somani, James A. Pawelczyk, Mary Jane De Souza, Penny M. Kris-Etherton & David N. Proctor. (2019) Aging women and their endothelium: probing the relative role of estrogen on vasodilator function. American Journal of Physiology-Heart and Circulatory Physiology 317:2, pages H395-H404.
Crossref
Grace E. Kohn, Katherine M. Rodriguez, James Hotaling & Alexander W. Pastuszak. (2019) The History of Estrogen Therapy. Sexual Medicine Reviews 7:3, pages 416-421.
Crossref
No Author. (2019) Chapitre 2 : Maladies cardiovasculaires. Journal of Obstetrics and Gynaecology Canada 41, pages S49-S57.
Crossref
Shira Rebecca Saul & Nathan Kase. (2018) Aging, the menopausal transition, and hormone replenishment therapy: retrieval of confidence and compliance. Annals of the New York Academy of Sciences 1440:1, pages 5-22.
Crossref
Sonja Zafirovic, Emina Sudar-Milovanovic, Milan Obradovic, Jelena Djordjevic, Nebojsa Jasnic, Milica Labudovic Borovic & Esma R. Isenovic. (2019) Involvement of PI3K, Akt and RhoA in Oestradiol Regulation of Cardiac iNOS Expression. Current Vascular Pharmacology 17:3, pages 307-318.
Crossref
M.-P. Nousse. (2019) Traitement hormonal de la ménopause : ce qui concerne le cardiologue. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2019:275, pages 15-23.
Crossref
Frederick Naftolin, Jenna Friedenthal, Richard Nachtigall & Lila Nachtigall. (2019) Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Research 8, pages 1576.
Crossref
Virginia M. Miller, Howard N. Hodis, Brian D. Lahr, Kent R. BaileyMuthuvel Jayachandran. (2019) Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study. Menopause 26:1, pages 24-31.
Crossref
Guido Lastra, Inga Harbuz-Miller, James R. Sowers & Camila M. Manrique. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology 13 22 .
Kejal KantarciNirubol TosakulwongTimothy G. LesnickSamantha M. ZukVal J. LoweJulie A. FieldsJeffrey L. GunterMatthew L. SenjemMegan L. SettellCarey E. GleasonLynne T. ShusterKent R. BaileyN. Maritza DowlingSanjay AsthanaClifford R. JackJrJrWalter A. RoccaVirginia M. Miller. (2018) Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology 90:16.
Crossref
Kathryn I. Marko & James A. Simon. (2018) Clinical trials in menopause. Menopause 25:2, pages 217-230.
Crossref
Dahima Cintron, Brian D. Lahr, Kent R. Bailey, Nanette Santoro, Robin Lloyd, JoAnn E. Manson, Genevieve Neal-Perry, Lubna Pal, Hugh S. Taylor, Whitney Wharton, Fredrick Naftolin, S. Mitchell Harman & Virginia M. Miller. (2018) Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause 25:2, pages 145-153.
Crossref
Nick Nicholas. 2018. Medicolegal Issues in Obstetrics and Gynaecology. Medicolegal Issues in Obstetrics and Gynaecology 317 323 .
Chrisandra L. Shufelt, Christine Pacheco, Marysia S. Tweet & Virginia M. Miller. 2018. Sex-Specific Analysis of Cardiovascular Function. Sex-Specific Analysis of Cardiovascular Function 433 454 .
Young Mee Lee & Hwi-yeol Yun. (2017) Hormone Therapy Review for Perimenopausal Symptoms: Focused on Perimenopausal Women without Other Risk Factors. Korean Journal of Clinical Pharmacy 27:4, pages 199-206.
Crossref
Virginia M. Miller & S. Mitchell Harman. (2017) An update on hormone therapy in postmenopausal women: mini-review for the basic scientist. American Journal of Physiology-Heart and Circulatory Physiology 313:5, pages H1013-H1021.
Crossref
Muthuvel Jayachandran, Vesna D. Garovic, Michelle M. Mielke, Kent R. Bailey, Brian D. Lahr & Virginia M. Miller. (2017) Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women. PLOS ONE 12:9, pages e0183159.
Crossref
Anne-Laure Madika, Patrick Devos, Pascal Delsart, Fanny Boudghène, Anne-Sophie Polge, Christophe Bauters & Claire Mounier-Vehier. (2017) Evaluation of screening for myocardial ischaemia in women at cardiovascular risk. Archives of Cardiovascular Diseases 110:6-7, pages 379-388.
Crossref
Dahima Cintron, John P. Beckman, Kent R. Bailey, Brian D. Lahr, Muthuvel Jayachandran & Virginia M. Miller. (2017) Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy. Maturitas 99, pages 59-65.
Crossref
Anjali ChauhanHope MoserLouise D. McCullough. (2017) Sex differences in ischaemic stroke: potential cellular mechanisms. Clinical Science 131:7, pages 533-552.
Crossref
Rebecca C. Thurston. (2017) Low-dose hormone therapy and menopausal symptoms: the ongoing quest for relief. Menopause 24:3, pages 235-236.
Crossref
Nanette Santoro, Amanda Allshouse, Genevieve Neal-Perry, Lubna Pal, Rogerio A. Lobo, Frederick Naftolin, Dennis M. Black, Eliot A. Brinton, Matthew J. Budoff, Marcelle I. Cedars, N. Maritza Dowling, Mary Dunn, Carey E. Gleason, Howard N. Hodis, Barbara Isaac, Maureen Magnani, JoAnn E. Manson, Virginia M. Miller, Hugh S. Taylor, Whitney Wharton, Erin Wolff, Viola Zepeda & S. Mitchell Harman. (2017) Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause 24:3, pages 238-246.
Crossref
Virginia M. Miller. 2017. The International Society for Gender Medicine. The International Society for Gender Medicine 133 141 .
Nastassia Sylvestre & Catherine Kim. (2017) Estrogen Therapy in 2017. Current Cardiovascular Risk Reports 11:1.
Crossref
Raja Sayegh & Johnny T. Awwad. 2017. Essentials of Menopause Management. Essentials of Menopause Management 13 43 .
E. Vautrin, S. Marlière, H. Bouvaist, R. Guerbaai & G. Barone-Rochette. (2016) Coronaropathie de la femme : rôle des hormones sexuelles. Annales de Cardiologie et d'Angéiologie 65:6, pages 404-410.
Crossref
Carter M. Owen, Lubna Pal, Sunni L. Mumford, Ruth Freeman, Barbara Isaac, Linda McDonald, Nanette Santoro, Hugh S. Taylor & Erin F. Wolff. (2016) Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study. Fertility and Sterility 106:5, pages 1170-1175.e3.
Crossref
Kejal KantarciNirubol TosakulwongTimothy G. LesnickSamantha M. ZukJeffrey L. GunterCarey E. GleasonWhitney WhartonN. Maritza DowlingPrashanthi VemuriMatthew L. SenjemLynne T. ShusterKent R. BaileyWalter A. RoccaClifford R. JackJrJrSanjay AsthanaVirginia M. Miller. (2016) Effects of hormone therapy on brain structure. Neurology 87:9, pages 887-896.
Crossref
Veronika Myasoedova, Tatyana Kirichenko, Alexandra Melnichenko, Varvara Orekhova, Alessio Ravani, Paolo Poggio, Igor Sobenin, Yuri Bobryshev & Alexander Orekhov. (2016) Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women. International Journal of Molecular Sciences 17:8, pages 1318.
Crossref
Ann M. Moyer, Mariza de Andrade, Richard M. Weinshilboum & Virginia M. Miller. (2016) Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women. Menopause 23:8, pages 863-869.
Crossref
Hilda Ahnstedt, Louise D. McCullough & Marilyn J. Cipolla. (2016) The Importance of Considering Sex Differences in Translational Stroke Research. Translational Stroke Research 7:4, pages 261-273.
Crossref
Kejal Kantarci, Val J. Lowe, Timothy G. Lesnick, Nirubol Tosakulwong, Kent R. Bailey, Julie A. Fields, Lynne T. Shuster, Samantha M. Zuk, Matthew L. Senjem, Michelle M. Mielke, Carey Gleason, Clifford R. Jack, Walter A. Rocca & Virginia M. Miller. (2016) Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. Journal of Alzheimer's Disease 53:2, pages 547-556.
Crossref
Rabe E. AlhuraniC. Anwar A. ChahalAhmed T. AhmedEssa A. MohamedVirginia M. Miller. (2016) Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clinical Science 130:13, pages 1065-1074.
Crossref
Virginia M. Miller, Brian D. Lahr, Kent R. Bailey, Howard N. Hodis, Sharon L. Mulvagh & Muthuvel Jayachandran. (2016) Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis 246, pages 21-28.
Crossref
Virginia M. MillerGregory D. JenkinsJoanna M. BiernackaJohn A. HeitGordon S. HugginsHoward N. HodisMatthew J. BudoffRogerio A. LoboHugh S. TaylorJoAnn E. MansonDennis M. BlackFrederick Naftolin, S. Mitchell Harman & Mariza de Andrade. (2016) Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiological Genomics 48:1, pages 33-41.
Crossref
Anna C. McCarrey, Melissa H. Kitner-Triolo & Susan M. Resnick. 2016. Handbook of the Psychology of Aging. Handbook of the Psychology of Aging 65 86 .
Nicholas Panay. 2016. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 203 208 .
Callie M Gustafson, Alex J Shepherd, Virginia M Miller & Muthuvel Jayachandran. (2015) Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans. Biology of Sex Differences 6:1.
Crossref
John N. Mordeson, D. S. Malik, Virginia M. Miller, Larry W. Hunter, Muthuvel Jayachandran, Alex Shepherd & Sarah Budney. (2015) Risk for Carotid Intima–Medial Thickness in Recently Menopausal Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS): Determination Using Fuzzy Logic. New Mathematics and Natural Computation 11:03, pages 267-283.
Crossref
Michael C. Craig. 2015. Managing the Menopause. Managing the Menopause 91 101 .
Anna C. McCarrey & Susan M. Resnick. (2015) Postmenopausal hormone therapy and cognition. Hormones and Behavior 74, pages 167-172.
Crossref
Samantha Giordano, Dongqi Xing, Yiu-Fai Chen, Steven Allon, Chongjia Chen, Suzanne Oparil & Fadi G. Hage. (2015) Estrogen and Cardiovascular Disease: Is Timing Everything?. The American Journal of the Medical Sciences 350:1, pages 27-35.
Crossref
Carey E. Gleason, N. Maritza Dowling, Whitney Wharton, JoAnn E. Manson, Virginia M. Miller, Craig S. Atwood, Eliot A. Brinton, Marcelle I. Cedars, Rogerio A. Lobo, George R. Merriam, Genevieve Neal-Perry, Nanette F. Santoro, Hugh S. Taylor, Dennis M. Black, Matthew J. Budoff, Howard N. Hodis, Frederick Naftolin, S. Mitchell Harman & Sanjay Asthana. (2015) Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study. PLOS Medicine 12:6, pages e1001833.
Crossref
Emily Lau & JoAnne M. Foody. (2015) Secondary Prevention of Heart Disease in Women: Gaps in Care/Gaps in Knowledge—Where Do We Need to Focus Our Attention. Current Cardiovascular Risk Reports 9:5.
Crossref
Robert L. Reid. 2015. Clinical Gynecology. Clinical Gynecology 985 1003 .
. 2015. Clinical Gynecology. Clinical Gynecology 865 1078 .
Hannah Short. (2015) Menopause and hormone replacement therapy. InnovAiT: Education and inspiration for general practice 8:4, pages 204-212.
Crossref
Anna M. Barron, Meghan A. Brown, Todd E. Morgan & Christian J. Pike. (2015) Impact of Continuous Versus Discontinuous Progesterone on Estradiol Regulation of Neuron Viability and Sprouting After Entorhinal Cortex Lesion in Female Rats. Endocrinology 156:3, pages 1091-1099.
Crossref
Cori Russell, Fatima Rodriguez & JoAnne M. Foody. 2015. PanVascular Medicine. PanVascular Medicine 1719 1761 .
Virginia M. Miller. (2014) Congress on Women's Health Trudy Bush Lecture 2014: New Insights into Sex Hormones and Cardiovascular Disease. Journal of Women's Health 23:12, pages 997-1004.
Crossref
Alex Shepherd, Virginia M. Miller, Larry W. Hunter, Muthuvel Jayachandran, D. S. Malik & John N. Mordeson. (2014) A Fuzzy Mathematical Model Determining the Risk for Carotid Intima-Medial Thickness in Recently Menopausal Women Enrolled in the KEEPS Study. New Mathematics and Natural Computation 10:03, pages 187-201.
Crossref
Francesca Romana Pezzella, Paola Santalucia, Rita Vadalà, Elisabetta Giugni, Maria Luisa Zedde, Maria Sessa, Sabrina Anticoli & Valeria Caso. (2014) Women Stroke Association Statement on Stroke. International Journal of Stroke 9:SA100, pages 20-27.
Crossref
Petra Stute. (2014) Is transdermal menopausal hormone therapy (MHT) associated with an increased cardiovascular risk?. Archives of Gynecology and Obstetrics 290:4, pages 617-619.
Crossref
. (2014) Managing Menopause Chapter 2 Cardiovascular Disease. Journal of Obstetrics and Gynaecology Canada 36:9, pages S16-S22.
Crossref
Shari S. Bassuk & Jo Ann E. Manson. 2014. Methods and Applications of Statistics in Clinical Trials. Methods and Applications of Statistics in Clinical Trials 918 930 .
Nick Panay. (2014) Body identical hormone replacement. Post Reproductive Health 20:2, pages 69-72.
Crossref
Cheryl Bushnell, Louise D. McCullough, Issam A. Awad, Monique V. Chireau, Wende N. Fedder, Karen L. Furie, Virginia J. Howard, Judith H. Lichtman, Lynda D. Lisabeth, Ileana L. Piña, Mathew J. Reeves, Kathryn M. Rexrode, Gustavo Saposnik, Vineeta Singh, Amytis Towfighi, Viola Vaccarino & Matthew R. Walters. (2014) Guidelines for the Prevention of Stroke in Women. Stroke 45:5, pages 1545-1588.
Crossref
Erin L. Scott, Quan-guang Zhang, Ratna K. Vadlamudi & Darrell W. Brann. (2014) Premature menopause and risk of neurological disease: Basic mechanisms and clinical implications. Molecular and Cellular Endocrinology 389:1-2, pages 2-6.
Crossref
A.A. Knowlton & D.H. Korzick. (2014) Estrogen and the female heart. Molecular and Cellular Endocrinology 389:1-2, pages 31-39.
Crossref
Zhuo ZhaoHao WangJewell A. JessupSarah H. LindseyMark C. Chappell & Leanne Groban. (2014) Role of estrogen in diastolic dysfunction. American Journal of Physiology-Heart and Circulatory Physiology 306:5, pages H628-H640.
Crossref
Chrisandra L. Shufelt, C. Noel Bairey Merz, Ross L. Prentice, Mary B. Pettinger, Jacques E. Rossouw, Vanita R. Aroda, Andrew M. Kaunitz, Kamakshi Lakshminarayan, Lisa W. Martin, Lawrence S. Phillips & JoAnn E. Manson. (2014) Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women. Menopause 21:3, pages 260-266.
Crossref
Limor Raz, Larry W. Hunter, Muthuvel Jayachandran, John A. Heit & Virginia M. Miller. (2014) Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiological Reports 2:3, pages e00275.
Crossref
Marta M. Millán & Santos Castañeda. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 731 745 .
Cori Russell, Fatima Rodriguez & JoAnne M. Foody. 2013. PanVascular Medicine. PanVascular Medicine 1 55 .
Nick Panay. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 241 246 .
Renee M. Dallasen, Hanna Z. Mieszczanska & Diane M. Hartmann. 2014. Management of Cardiovascular Disease in Women. Management of Cardiovascular Disease in Women 359 377 .
Catha Fischer, Amanda N. Kallen & Lubna Pal. (2013) Hormone Therapy. Menopause 20:11, pages 1204-1206.
Crossref
L.C. Kobashigawa, M. Hamilton, M. Rafiei, L. Stern & C.N. Bairey Merz. (2013) Hormone Therapy in Women After Heart Transplantation. Transplantation Proceedings 45:9, pages 3386-3388.
Crossref
Dhaval Sharad Bendale, Pinakin Arun Karpe, Richa Chhabra, Sachin Prabhakarrao Shete, Heta Shah & Kulbhushan Tikoo. (2013) 17-? Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation. British Journal of Pharmacology 170:4, pages 779-795.
Crossref
Jewell A. Jessup, Hao Wang, Lindsay M. MacNamara, Tennille D. Presley, Daniel B. Kim-Shapiro, Lili Zhang, Alex F. Chen & Leanne Groban. (2013) Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats. Menopause 20:8, pages 860-868.
Crossref
N. Maritza Dowling, Carey E. Gleason, JoAnn E. Manson, Howard N. Hodis, Virginia M. Miller, Eliot A. Brinton, Genevieve Neal-Perry, M. Nanette Santoro, Marcelle Cedars, Rogerio Lobo, George R. Merriam, Whitney Wharton, Frederick Naftolin, Hugh Taylor, S. Mitchell Harman & Sanjay Asthana. (2013) Characterization of Vascular Disease Risk in Postmenopausal Women and Its Association with Cognitive Performance. PLoS ONE 8:7, pages e68741.
Crossref
Nick Panay, Haitham Hamoda, Roopen Arya & Michael Savvas. (2013) The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy. Menopause International 19:2, pages 59-68.
Crossref
Matthias Barton. (2013) Cholesterol and atherosclerosis. Current Opinion in Lipidology 24:3, pages 214-220.
Crossref
Carolyn J. Crandall & Elizabeth Barrett-Connor. (2013) Endogenous Sex Steroid Levels and Cardiovascular Disease in Relation to the Menopause. Endocrinology and Metabolism Clinics of North America 42:2, pages 227-253.
Crossref
Whitney Wharton, Carey E. Gleason, Virginia M. Miller & Sanjay Asthana. (2013) Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog). Brain Research 1514, pages 12-17.
Crossref
Donna H. Korzick & Timothy S. Lancaster. (2013) Age-related differences in cardiac ischemia–reperfusion injury: effects of estrogen deficiency. Pflügers Archiv - European Journal of Physiology 465:5, pages 669-685.
Crossref
Erin Foran Wolff, Yunxiao He, Dennis M. Black, Eliot A. Brinton, Mathew J. Budoff, Marcelle I. Cedars, Howard N. Hodis, Rogerio A. Lobo, JoAnn E. Manson, George R. Merriam, Virginia M. Miller, Fredrick Naftolin, Lubna Pal, Nanette Santoro, Heping Zhang, S. Mitchell Harman & Hugh S. Taylor. (2013) Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertility and Sterility 99:5, pages 1385-1391.
Crossref
Limor RazM. JayachandranNirubol TosakulwongTimothy G. LesnickSamantha M. WilleMatthew C. MurphyMatthew L. SenjemJeffrey L. GunterPrashanthi VemuriClifford R. JackJrJrVirginia M. MillerKejal Kantarci. (2013) Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology 80:10, pages 911-918.
Crossref
Joshua N. Farr, Sundeep Khosla, Yuko Miyabara, Virginia M. Miller & Ann E. Kearns. (2013) Effects of Estrogen with Micronized Progesterone on Cortical and Trabecular Bone Mass and Microstructure in Recently Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism 98:2, pages E249-E257.
Crossref
Rodney M. Ritzel, Lori A. Capozzi & Louise D. McCullough. (2013) Sex, stroke, and inflammation: The potential for estrogen-mediated immunoprotection in stroke. Hormones and Behavior 63:2, pages 238-253.
Crossref
Tasneem Siyam & Nesé Yuksel. (2013) Beliefs about bioidentical hormone therapy: A cross-sectional survey of pharmacists. Maturitas 74:2, pages 196-202.
Crossref
Virginia M. MillerTanya M. PettersonElysia N. JeavonsAbhinita S. LnuDavid N. RiderJohn A. HeitJulie M. CunninghamGordon S. HugginsHoward N. HodisMatthew J. BudoffNanette SantoroPaul N. HopkinsRogerio A. LoboJoAnn E. MansonFrederick NaftolinHugh S. Taylor, S. Mitchell Harman & Mariza de Andrade. (2013) Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiological Genomics 45:2, pages 79-88.
Crossref
Suman Sood & Barbara A Konkle. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis 603 615 .
Kathryn M. Rexrode. 2013. Women and Health. Women and Health 943 947 .
Paige C. Geiger & Anisha A. Gupte. 2013. Integrative Biology of Women’s Health. Integrative Biology of Women’s Health 67 86 .
Chrisandra Shufelt & Talya Waldman. 2013. Chest Pain with Normal Coronary Arteries. Chest Pain with Normal Coronary Arteries 309 317 .
Pauline M. Maki. (2012) Minireview: Effects of Different HT Formulations on Cognition. Endocrinology 153:8, pages 3564-3570.
Crossref
Lily Honoris & Matthew J. Budoff. (2012) Postmenopausal Hormone Therapy: Does It Have a Role in Cardiovascular Prevention Today?. Current Cardiovascular Risk Reports 6:3, pages 205-209.
Crossref
Catherine Kim. (2012) Does Menopause Increase Diabetes Risk? Strategies for Diabetes Prevention in Midlife Women. Women's Health 8:2, pages 155-167.
Crossref
Nick Panay. (2012) Commentary regarding recent Million Women Study critique and subsequent publicity. Menopause International 18:1, pages 33-35.
Crossref
Namrata Bali, Jason M. Arimoto, Nahoko Iwata, Sharon W. Lin, Liqin Zhao, Roberta D. Brinton, Todd E. Morgan & Caleb E. Finch. (2012) Differential Responses of Progesterone Receptor Membrane Component-1 (Pgrmc1) and the Classical Progesterone Receptor (Pgr) to 17β-Estradiol and Progesterone in Hippocampal Subregions that Support Synaptic Remodeling and Neurogenesis. Endocrinology 153:2, pages 759-769.
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology 553 564 .
Kate Maclaran & John C Stevenson. (2012) Primary Prevention of Cardiovascular Disease with HRT. Women's Health 8:1, pages 63-74.
Crossref
Erin Scott, Quan-guang Zhang, Ruimin Wang, Ratna Vadlamudi & Darrell Brann. (2012) Estrogen neuroprotection and the critical period hypothesis. Frontiers in Neuroendocrinology 33:1, pages 85-104.
Crossref
Lynda Lisabeth & Cheryl Bushnell. (2012) Stroke risk in women: the role of menopause and hormone therapy. The Lancet Neurology 11:1, pages 82-91.
Crossref
Muthuvel Jayachandran, Robert D. Litwiller, Brian D. Lahr, Kent R. Bailey, Whyte G. Owen, Sharon L. Mulvagh, John A. Heit, Howard N. Hodis, S. Mitchell Harman & Virginia M. Miller. (2011) Alterations in Platelet Function and Cell-Derived Microvesicles in Recently Menopausal Women: Relationship to Metabolic Syndrome and Atherogenic Risk. Journal of Cardiovascular Translational Research 4:6, pages 811-822.
Crossref
Lianna R. Lipton, Nanette Santoro, Hugh Taylor, Neiha Kidwai, Barbara Isaac, Maureen Magnani & Lubna Pal. (2011) Assessing comprehension of clinical research. Contemporary Clinical Trials 32:5, pages 608-613.
Crossref
Amanda N. Kallen & Lubna Pal. (2011) Cardiovascular disease and ovarian function. Current Opinion in Obstetrics & Gynecology 23:4, pages 258-267.
Crossref
Robert-Paul Juster, Gustav Bizik, Martin Picard, Genevieve Arsenault-Lapierre, Shireen Sindi, Lyane Trepanier, Marie-France Marin, Nathalie Wan, Zoran Sekerovic, Catherine Lord, Alexandra J. Fiocco, Pierrich Plusquellec, Bruce S. McEwen & Sonia J. Lupien. (2011) A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. Development and Psychopathology 23:3, pages 725-776.
Crossref
Donna Shoupe. (2011) Individualizing Hormone Therapy to Minimize Risk: Accurate Assessment of Risks and Benefits. Women's Health 7:4, pages 475-485.
Crossref
Melinda B Davis & Claire S Duvernoy. (2011) How to Stay Heart Healthy in 2011: Considerations for the Primary Prevention of Cardiovascular Disease in Women. Women's Health 7:4, pages 433-451.
Crossref
Karen Roush. (2011) Menopausal Hormone Therapy: What We Know Now. AJN, American Journal of Nursing 111:6, pages 38-47.
Crossref
Bharti Manwani & Louise D McCullough. (2011) Sexual Dimorphism in Ischemic Stroke: Lessons from the Laboratory. Women's Health 7:3, pages 319-339.
Crossref
Walter A. Rocca, Brandon R. Grossardt & Lynne T. Shuster. (2011) Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunity. Brain Research 1379, pages 188-198.
Crossref
Cynthia L. Bethea. (2011) MPA: Medroxy-Progesterone Acetate Contributes to Much Poor Advice for Women. Endocrinology 152:2, pages 343-345.
Crossref
Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams, Lawrence J. Appel, Lynne T. Braun, Seemant Chaturvedi, Mark A. Creager, Antonio Culebras, Robert H. Eckel, Robert G. Hart, Judith A. Hinchey, Virginia J. Howard, Edward C. Jauch, Steven R. Levine, James F. Meschia, Wesley S. Moore, J.V. (Ian) Nixon & Thomas A. Pearson. (2011) Guidelines for the Primary Prevention of Stroke. Stroke 42:2, pages 517-584.
Crossref
Seung Do Choi, Emma M. Steinberg, Hae Hyeog Lee & Frederick Naftolin. (2011) The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment. Menopause 18:2, pages 230-236.
Crossref
Erin Wolff, Lubna Pal, Tugba Altun, Rajeevi Madankumar, Ruth Freeman, Hussein Amin, Mitch Harman, Nanette Santoro & Hugh S. Taylor. (2011) Skin wrinkles and rigidity in early postmenopausal women vary by race/ethnicity: baseline characteristics of the skin ancillary study of the KEEPS trial. Fertility and Sterility 95:2, pages 658-662.e3.
Crossref
Raza H. Orakzai, Chrisandra L. Shufelt, Leslee J. Shaw & C. Noel Bairey Merz. 2011. Preventive Cardiology: Companion to Braunwald's Heart Disease. Preventive Cardiology: Companion to Braunwald's Heart Disease 398 414 .
Claudio N Soares. (2010) Can depression be a menopause-associated risk?. BMC Medicine 8:1.
Crossref
Allan S. Brett. (2010) Differences Between Gynecologists and Primary Care Physicians in Hormone Therapy Prescribing: Why They Matter. Journal of Women's Health 19:12, pages 2153-2156.
Crossref
Virginia M. Miller. (2010) Estrogen Metabolomics. Hypertension 56:5, pages 816-818.
Crossref
Andrea H. Tackett, Alison L. Bailey, Joanne Micale Foody, Julie M. Miller, Carolyn Apperson-Hansen, E. Magnus Ohman, Judith S. Hochman, Sharon L. Karnash, Robert M. Califf, Eric J. Topol & David J. Moliterno. (2010) Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: Insights from the GUSTO-III trial. American Heart Journal 160:4, pages 678-684.
Crossref
VM Miller. (2010) Sex-Based Differences in Vascular Function. Women's Health 6:5, pages 737-752.
Crossref
Michael C. Craig & D.G.M. Murphy. (2010) Estrogen therapy and Alzheimer's dementia. Annals of the New York Academy of Sciences 1205:1, pages 245-253.
Crossref
C. Noel Bairey Merz, Chrisandra Shufelt, B. Delia Johnson, Ricardo Azziz & Glenn Braunstein. (2010) Response to Letter to the Editor. Maturitas 66:3, pages 329-330.
Crossref
Faustino R. Pérez-López, Luis Larrad-Mur, Amanda Kallen, Peter Chedraui & Hugh S. Taylor. (2010) Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences. Reproductive Sciences 17:6, pages 511-531.
Crossref
Jan L. Shifren & Isaac Schiff. (2010) Role of Hormone Therapy in the Management of Menopause. Obstetrics & Gynecology 115:4, pages 839-855.
Crossref
Daniel P. Sieveking, Patrick Lim, Renée W.Y. Chow, Louise L. Dunn, Shisan Bao, Kristine C.Y. McGrath, Alison K. Heather, David J. Handelsman, David S. Celermajer & Martin K.C. Ng. (2010) A sex-specific role for androgens in angiogenesis. Journal of Experimental Medicine 207:2, pages 345-352.
Crossref
B.B. Bendlin, C.M. Carlsson, C.E. Gleason, S.C. Johnson, A. Sodhi, C.L. Gallagher, L. Puglielli, C.D. Engelman, M.L. Ries, G. Xu, W. Wharton & S. Asthana. (2010) Midlife predictors of Alzheimer's disease. Maturitas 65:2, pages 131-137.
Crossref
Sandra M. Sacco & Wendy E. Ward. (2010) Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health. Journal of Osteoporosis 2010, pages 1-8.
Crossref

Displaying 200 of 285 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.